OpenAI oo iibsatay Orchestra Bio si ay u xoojiso ganacsigeeda cilmiga nolosha

Shirkadda AI-da ee Orchestra Bio waxay dhistay wakiillo AI ah oo ka caawiya shirkadaha biotech maaraynta hawlooyinka raadinta dawooyinka.

OpenAI ayaa Talaadadii iibsatay Orchestra Bio, oo ah shirkad software biotech AI ah oo afarta sano jir ah, sida lagu sheegay bayaan ka soo baxay website-ka OpenAI. Shuruudaha heshiiska lama shaacin.

Orchestra Bio iyo lacagta ay soo ururisay

Orchestra Bio waxay soo ururisay lacag dhan qiyaastii $20 milyan ilaa 2025, sida la soo weriyey, iyadoo maalgeliyayaasha ay ka mid yihiin Andreessen Horowitz, Atria iyo 8VC. Shirkaddu waxay abuurtaa wakiillo AI ah oo ka caawiya shirkadaha biotech maaraynta hawlooyinka yaryar ee raadinta dawooyinka, oo ay ka mid yihiin la socodka maaliyadda iyo xallinta arrimaha jadwalka tijaabooyinka caafimaad.

Ku biirista Rosalind iyo Rosalind Workbench

OpenAI waxay sheegtay in ay kooxda iyo tignoolajiyada Orchestra Bio ku darayso shaqada Rosalind, oo ah qaabkeeda AI ee cilmi-baarista cilmiga nolosha, iyo sidoo kale qalabka la xiriira ee Rosalind Workbench, kaas oo loogu talagalay in uu ka caawiyo cilmi-baarayaasha qorsheynta tijaabooyinka iyo falanqaynta natiijooyinka.

OpenAI waxay sheegtay in Moderna iyo Novo Nordisk ay yihiin macaamiisha Rosalind. Iibkaani waa tusaale caadi ah oo muujinaya sida shaybaadhka waaweyn ee AI, gaar ahaan OpenAI iyo Anthropic, ay u dhisaan software badan oo loogu talagalay warshadaha waaweyn sida pharma.

Cabsida shirkadaha cusub iyo nuugista Orchestra Bio

Dunida shirkadaha cusub waxaa jira cabsida joogtada ah ee ah in shaybaadhka AI ay soo bandhigi karaan astaamo cusub oo ay noqdaan tartamayaal. Hase yeeshee, xaaladdan Orchestra Bio waa la nuugayaa halkii la burburin lahaa.

The four-year-old AI biotech software startup will bring its team and technology to OpenAI's Rosalind model and Rosalind Workbench tool.

OpenAI acquired Orchestra Bio, a four-year-old AI biotech software startup, on Tuesday, according to an announcement on OpenAI's website. The terms of the deal were not disclosed.

What Orchestra Bio Brings to OpenAI

Orchestra Bio creates AI agents that help biotech companies manage drug discovery operations, including tracking finances and resolving scheduling issues with clinical trials. OpenAI is adding the startup's team and technology to work on Rosalind, its AI model for life sciences research, and to its related Rosalind Workbench tool, which helps researchers plan experiments and analyze results.

Orchestra Bio had reportedly raised around $20 million as of 2025 from backers including Andreessen Horowitz, Atria, and 8VC. The acquisition terms were not disclosed.

Rosalind Customers and Industry Context

OpenAI says Moderna and Novo Nordisk are customers for Rosalind. The acquisition is an example of AI labs such as OpenAI and Anthropic building software for major industries including pharma.

In the startup world, there is an ongoing fear that AI labs will launch new features and become competitors. In this case, Orchestra Bio is being absorbed rather than stomped out.